RE:RE:RE:Holding breathOne of the more comforting things throughout all the ups and downs over the last 18 months is that the longs that are still here have no pretense of naive optimism like you tend to find for some other stocks. They're like war hardened vets who stay because they believe the battle can be won, but also recognize that a lot of people are going to have to die first. Nobilis1, you, amongst others, have often been pretty blunt about your criticisms while still providing legitimate reasons for sticking with this stock. While I've often felt like I was taking crazy pills on this one I echo the sentiments of others. Yes, it's healthcare, but it's not a pharma company. It's also not particularly sensitive to Obamacare (i.e. people who seek HLTH's services out are not the people barely qualifying for insurance, but rather those that can easily afford it) It's not oil/gas, therefore not subject to commodity prices. It's not a gambling company dependant on state regulations/legislation. It is a growth company that keeps growing (look at the last 3 years growth). The addition of vascular to their mix of procedures is massive (many vascular surgeries are not elective) It rakes in more money than, say, a CRH, which everybody seems to adore (I own this too). And I believe 3 out of the past 5 quarters they have surprised to the upside. And yet, $2.15/share is where we are at. Valued like the Cleveland Browns when there is at least a playoff team here. Here's hoping that 2017 goes like the second half did for the Patriots tonight.